Form 144: APi Group insider plans 150K-share sale on NYSE

Rhea-AI Filing Summary

APi Group (APG) filed a Form 144 proposing the sale of 150,000 common shares through J.P. Morgan on the NYSE with an approximate sale date of 08/11/2025. The proposed block carries an aggregate market value of $5,169,000 and represents roughly 0.036% of the 415,888,477 shares outstanding, a very small portion of total equity.

The shares were acquired on 10/02/2019 by transfer (described as indirectly acquired directly from the issuer) and the filer reports no securities sold in the past three months. The filer attests they do not possess undisclosed material information; the form references Rule 10b5-1 plan adoption language.

Insights

Securities Analyst

TL;DR: Proposed sale is immaterial relative to outstanding shares and unlikely to affect market pricing or control.

The filing discloses a proposed sale of 150,000 common shares valued at $5.169 million, representing about 0.036% of APi Group's 415.9 million shares outstanding. There were no reported sales in the prior three months and the shares were acquired in 2019 by transfer. From a market-impact perspective, the size is negligible; the filing primarily serves disclosure and regulatory compliance purposes rather than signaling a material shift in ownership.

Corporate Governance Expert

TL;DR: Routine insider disclosure with limited governance implications given small percentage and historical acquisition.

The Form 144 documents a planned sale executed through a broker and includes the seller's representation that no material nonpublic information exists. The shares were acquired in 2019 and no recent sales were reported, reducing concerns about opportunistic timing tied to undisclosed events. The filing aligns with standard insider reporting and Rule 144 requirements; it does not indicate governance changes or material insider shifts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	150000	5169000	415888477	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/02/2019	Transfer	Indirectly acquired directly from Issuer			150000	10/02/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did APi Group (APG) file in this Form 144?

The filing proposes the sale of 150,000 common shares on the NYSE through J.P. Morgan with an approximate sale date of 08/11/2025.

What is the aggregate market value of the shares in the Form 144?

The aggregate market value is reported as $5,169,000 for the 150,000 shares.

How large is the proposed sale relative to APi Group's outstanding shares (APG)?

The 150,000 shares represent about 0.036% of the company's 415,888,477 shares outstanding.

When and how were the securities being sold originally acquired?

The securities were acquired on 10/02/2019 by transfer, described as indirectly acquired directly from the issuer.

Has the filer sold any APG securities in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Does the filer assert possession of undisclosed material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.